Emerging drug targets for achondroplasia

被引：2
|
作者：
Savarirayan, Ravi [1 ]
机构：
[1] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2022年 / 26卷 / 05期
关键词：
Skeletal dysplasia; therapeutics; clinical trials; achondroplasia; drug targets; FGFR3; mutation; fibroblast growth factor receptor 3; mouse models; GROWTH; MUTATIONS; DWARFISM; CHILDREN; THERAPY; CNP;
D O I：
10.1080/14728222.2022.2077722
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：389 / 391
页数：3
相关论文
共 50 条
  • [41] A unique multiattribute method to predict success of emerging drug targets
    De, Sangeetha
    Meredith, Linda
    DRUG DISCOVERY TODAY, 2016, 21 (03) : 385 - 394
  • [42] Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets
    Tate, Edward W.
    Soday, Lior
    de la Lastra, Ana Losada
    Wang, Mei
    Lin, Hening
    NATURE REVIEWS CANCER, 2024, 24 (04) : 240 - 260
  • [43] Emerging Role of the Ubiquitin-proteasome System as Drug Targets
    Kar, Gozde
    Keskin, Ozlem
    Fraternali, Franca
    Gursoy, Attila
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (18) : 3175 - 3189
  • [44] The apoptosome: Emerging insights and new potential targets for drug design
    D'Amelio, Marcello
    Tino, Elisa
    Cecconi, Francesco
    PHARMACEUTICAL RESEARCH, 2008, 25 (04) : 740 - 751
  • [45] ALZHEIMERS-DISEASE AMYLOID FORMATION AND EMERGING DRUG TARGETS
    THORSETT, ED
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 166 - MEDI
  • [46] Emerging roles of cysteine cathepsins in disease and their potential as drug targets
    Vasiljeva, Olga
    Reinheckel, Thomas
    Peters, Christoph
    Turk, Dusan
    Turk, Vito
    Turk, Boris
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (04) : 387 - 403
  • [47] Mitochondria Associated Membranes (MAMs): Emerging Drug Targets for Diabetes
    Sasi, U. S. Swapna
    Ganapathy, Sindhu
    Palayyan, Salin Raj
    Gopal, Raghu K.
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (20) : 3362 - 3385
  • [48] Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity
    Shi, YG
    Burn, P
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 695 - 710
  • [49] Diacylglycerol kinases as emerging potential drug targets for a variety of diseases
    Sakane, Fumio
    Imai, Shin-ichi
    Kai, Masahiro
    Yasuda, Satoshi
    Kanoh, Hideo
    CURRENT DRUG TARGETS, 2008, 9 (08) : 626 - 640
  • [50] The Apoptosome: Emerging Insights and New Potential Targets for Drug Design
    Marcello D’Amelio
    Elisa Tino
    Francesco Cecconi
    Pharmaceutical Research, 2008, 25 : 740 - 751
12345